To evaluate efficacy, safety, and tolerability of laquinimod in patients with primary progressive multiple sclerosis (PPMS).
A randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosis
Uccelli, Antonio;Sormani, Maria Pia;
2020-01-01
Abstract
To evaluate efficacy, safety, and tolerability of laquinimod in patients with primary progressive multiple sclerosis (PPMS).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
10.1212@WNL.0000000000010284.pdf
accesso chiuso
Tipologia:
Documento in Pre-print
Dimensione
4.6 MB
Formato
Adobe PDF
|
4.6 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
